rs41298482

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_005120.3(MED12):​c.5401-25C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.126 in 1,208,219 control chromosomes in the GnomAD database, including 6,999 homozygotes. There are 50,986 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1079 hom., 4684 hem., cov: 22)
Exomes 𝑓: 0.12 ( 5920 hom. 46302 hem. )

Consequence

MED12
NM_005120.3 intron

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.98

Publications

4 publications found
Variant links:
Genes affected
MED12 (HGNC:11957): (mediator complex subunit 12) The initiation of transcription is controlled in part by a large protein assembly known as the preinitiation complex. A component of this preinitiation complex is a 1.2 MDa protein aggregate called Mediator. This Mediator component binds with a CDK8 subcomplex which contains the protein encoded by this gene, mediator complex subunit 12 (MED12), along with MED13, CDK8 kinase, and cyclin C. The CDK8 subcomplex modulates Mediator-polymerase II interactions and thereby regulates transcription initiation and reinitation rates. The MED12 protein is essential for activating CDK8 kinase. Defects in this gene cause X-linked Opitz-Kaveggia syndrome, also known as FG syndrome, and Lujan-Fryns syndrome. [provided by RefSeq, Aug 2009]
MED12 Gene-Disease associations (from GenCC):
  • FG syndrome 1
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • MED12-related intellectual disability syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • X-linked intellectual disability with marfanoid habitus
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • blepharophimosis - intellectual disability syndrome, MKB type
    Inheritance: XL Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • cholestasis-pigmentary retinopathy-cleft palate syndrome
    Inheritance: XL Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_005120.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant X-71136854-C-T is Benign according to our data. Variant chrX-71136854-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 259639.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.232 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_005120.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED12
NM_005120.3
MANE Select
c.5401-25C>T
intron
N/ANP_005111.2Q93074-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MED12
ENST00000374080.8
TSL:1 MANE Select
c.5401-25C>T
intron
N/AENSP00000363193.3Q93074-1
MED12
ENST00000374102.6
TSL:1
c.5401-25C>T
intron
N/AENSP00000363215.2Q93074-2
MED12
ENST00000938012.1
c.5443-25C>T
intron
N/AENSP00000608071.1

Frequencies

GnomAD3 genomes
AF:
0.151
AC:
16718
AN:
110808
Hom.:
1076
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.237
Gnomad AMI
AF:
0.0247
Gnomad AMR
AF:
0.111
Gnomad ASJ
AF:
0.0909
Gnomad EAS
AF:
0.128
Gnomad SAS
AF:
0.212
Gnomad FIN
AF:
0.107
Gnomad MID
AF:
0.134
Gnomad NFE
AF:
0.118
Gnomad OTH
AF:
0.138
GnomAD2 exomes
AF:
0.135
AC:
24178
AN:
179137
AF XY:
0.137
show subpopulations
Gnomad AFR exome
AF:
0.240
Gnomad AMR exome
AF:
0.102
Gnomad ASJ exome
AF:
0.0909
Gnomad EAS exome
AF:
0.152
Gnomad FIN exome
AF:
0.115
Gnomad NFE exome
AF:
0.113
Gnomad OTH exome
AF:
0.117
GnomAD4 exome
AF:
0.124
AC:
135992
AN:
1097357
Hom.:
5920
Cov.:
33
AF XY:
0.128
AC XY:
46302
AN XY:
362885
show subpopulations
African (AFR)
AF:
0.239
AC:
6307
AN:
26392
American (AMR)
AF:
0.102
AC:
3586
AN:
35173
Ashkenazi Jewish (ASJ)
AF:
0.0913
AC:
1770
AN:
19383
East Asian (EAS)
AF:
0.118
AC:
3557
AN:
30196
South Asian (SAS)
AF:
0.223
AC:
12043
AN:
54114
European-Finnish (FIN)
AF:
0.116
AC:
4646
AN:
40130
Middle Eastern (MID)
AF:
0.121
AC:
499
AN:
4117
European-Non Finnish (NFE)
AF:
0.116
AC:
97424
AN:
841785
Other (OTH)
AF:
0.134
AC:
6160
AN:
46067
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
4674
9347
14021
18694
23368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3794
7588
11382
15176
18970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.151
AC:
16733
AN:
110862
Hom.:
1079
Cov.:
22
AF XY:
0.141
AC XY:
4684
AN XY:
33106
show subpopulations
African (AFR)
AF:
0.237
AC:
7184
AN:
30349
American (AMR)
AF:
0.110
AC:
1151
AN:
10460
Ashkenazi Jewish (ASJ)
AF:
0.0909
AC:
241
AN:
2650
East Asian (EAS)
AF:
0.128
AC:
450
AN:
3516
South Asian (SAS)
AF:
0.213
AC:
561
AN:
2631
European-Finnish (FIN)
AF:
0.107
AC:
638
AN:
5948
Middle Eastern (MID)
AF:
0.124
AC:
27
AN:
217
European-Non Finnish (NFE)
AF:
0.118
AC:
6242
AN:
52899
Other (OTH)
AF:
0.148
AC:
222
AN:
1505
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
507
1014
1520
2027
2534
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
182
364
546
728
910
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.131
Hom.:
1048
Bravo
AF:
0.154

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
15
DANN
Benign
0.64
PhyloP100
2.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.19
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41298482;
hg19: chrX-70356704;
COSMIC: COSV61332980;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.